Drug intelligence / Profile preview

N-acetylcysteine + alpha-lipoic acid + liposomal glutathione

Development stage
Discontinued
Lead developer
Lung Biotechnology
Modality
Peptides, Small Molecules
Administration
Oral
01

Overview

N-acetylcysteine + alpha-lipoic acid + liposomal glutathione is an antioxidant combination therapy developed by Lung Biotechnology PBC for the treatment of pulmonary arterial hypertension (PAH). The therapy is designed to mitigate oxidative stress, a key driver of vascular remodeling and endothelial dysfunction in PAH. N-acetylcysteine (NAC) and alpha-lipoic acid (ALA) serve as precursors and cofactors to enhance the endogenous production of glutathione, while the liposomal formulation of glutathione is intended to provide direct antioxidant support with improved systemic bioavailability. A Phase 2 clinical trial (NCT03507309) was planned to evaluate this oral 'Antioxidant Cocktail' as an add-on therapy in PAH patients, but the study was ultimately withdrawn by the sponsor before enrollment began.

Other names
Antioxidant Cocktail

Beyond the preview

Go deeper on N-acetylcysteine + alpha-lipoic acid + liposomal glutathione.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on N-acetylcysteine + alpha-lipoic acid + liposomal glutathione.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call